These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 12030427

  • 1. The association between systemic lupus erythematosus and deficiencies of the complement system.
    Goerg S.
    Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):237-45. PubMed ID: 12030427
    [Abstract] [Full Text] [Related]

  • 2. Antigen localization within the splenic marginal zone restores humoral immune response and IgG class switch in complement C4-deficient mice.
    Zachrau B, Finke D, Kropf K, Gosink HJ, Kirchner H, Goerg S.
    Int Immunol; 2004 Dec; 16(12):1685-90. PubMed ID: 15477230
    [Abstract] [Full Text] [Related]

  • 3. Complement deficiencies and systemic lupus erythematosus.
    Truedsson L, Bengtsson AA, Sturfelt G.
    Autoimmunity; 2007 Dec; 40(8):560-6. PubMed ID: 18075790
    [Abstract] [Full Text] [Related]

  • 4. Complement deficiencies in humans and animals: links to autoimmunity.
    Lewis MJ, Botto M.
    Autoimmunity; 2006 Aug; 39(5):367-78. PubMed ID: 16923536
    [Abstract] [Full Text] [Related]

  • 5. Elevated levels of endogenous apoptotic DNA and IFN-alpha in complement C4-deficient mice: implications for induction of systemic lupus erythematosus.
    Finke D, Randers K, Hoerster R, Hennig H, Zawatzky R, Marion T, Brockmann C, Klempt-Giessing K, Jacobsen K, Kirchner H, Goerg S.
    Eur J Immunol; 2007 Jun; 37(6):1702-9. PubMed ID: 17506029
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus.
    Cook HT, Botto M.
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):330-7. PubMed ID: 16932712
    [Abstract] [Full Text] [Related]

  • 7. Primary immunodeficiency and autoimmunity: lessons from human diseases.
    Arason GJ, Jorgensen GH, Ludviksson BR.
    Scand J Immunol; 2010 May; 71(5):317-28. PubMed ID: 20500682
    [Abstract] [Full Text] [Related]

  • 8. The complement system in systemic lupus erythematosus.
    Sturfelt G.
    Scand J Rheumatol; 2002 May; 31(3):129-32. PubMed ID: 12195625
    [Abstract] [Full Text] [Related]

  • 9. A protective role for innate immunity in systemic lupus erythematosus.
    Carroll MC.
    Nat Rev Immunol; 2004 Oct; 4(10):825-31. PubMed ID: 15459673
    [Abstract] [Full Text] [Related]

  • 10. Systemic lupus erythematosus conundrums.
    Wardle EN.
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):731-6. PubMed ID: 19736466
    [Abstract] [Full Text] [Related]

  • 11. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
    Arora V, Verma J, Dutta R, Marwah V, Kumar A, Das N.
    Mol Immunol; 2004 Jun; 41(4):449-56. PubMed ID: 15163541
    [Abstract] [Full Text] [Related]

  • 12. Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system.
    Mevorach D.
    Apoptosis; 2010 Sep; 15(9):1114-23. PubMed ID: 20683667
    [Abstract] [Full Text] [Related]

  • 13. Patients with systemic lupus erythematosus are deficient in complement-dependent prevention of immune precipitation.
    Arason GJ, Steinsson K, Kolka R, Víkingsdóttir T, D'Ambrogio MS, Valdimarsson H.
    Rheumatology (Oxford); 2004 Jun; 43(6):783-9. PubMed ID: 15054157
    [Abstract] [Full Text] [Related]

  • 14. [Clinical aspects of the complement system].
    Tsukamoto H, Horiuchi T.
    Rinsho Byori; 2006 Jul; 54(7):757-62. PubMed ID: 16913667
    [Abstract] [Full Text] [Related]

  • 15. B cell biology: implications for treatment of systemic lupus erythematosus.
    Anolik JH.
    Lupus; 2013 Apr; 22(4):342-9. PubMed ID: 23553777
    [Abstract] [Full Text] [Related]

  • 16. What is the relationship between complement and systemic lupus erythematosus?
    Podrebarac TA, Goldstein R.
    J Rheumatol; 1998 Nov; 25(11):2062-4. PubMed ID: 9818645
    [No Abstract] [Full Text] [Related]

  • 17. Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions.
    Erdei A, Isaák A, Török K, Sándor N, Kremlitzka M, Prechl J, Bajtay Z.
    Mol Immunol; 2009 Sep; 46(14):2767-73. PubMed ID: 19559484
    [Abstract] [Full Text] [Related]

  • 18. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
    Dörner T.
    J Rheumatol Suppl; 2006 May; 77():3-11. PubMed ID: 16652439
    [Abstract] [Full Text] [Related]

  • 19. C1q, autoimmunity and apoptosis.
    Botto M, Walport MJ.
    Immunobiology; 2002 Sep; 205(4-5):395-406. PubMed ID: 12396002
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S, Trick D, Kamino K, Matthias T, Kniesch K, Schlegelberger B, Schmidt RE, Witte T.
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.